Preventing the malignant transformation of bipolar disorder

JAMA - Journal of the American Medical Association

Volumn 319, Issue 12, 2018, Pages 1197-1198

  Post, Robert M ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b Bipolar Collaborative Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; QUETIAPINE; ZEBULARINE; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT; TRANQUILIZER;

BIPOLAR DISORDER; COMORBIDITY; EPIGENETICS; HOSPITAL READMISSION; HUMAN; MANIA; MEDICATION COMPLIANCE; NONHUMAN; NOTE; ONSET AGE; PRIORITY JOURNAL; RECURRENT DISEASE; STIGMA; SUBSTANCE ABUSE; SUICIDE; THERAPY DELAY; TIME TO TREATMENT;

ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; HUMANS; LITHIUM COMPOUNDS; QUETIAPINE FUMARATE; TIME-TO-TREATMENT;

EID: 85044456614     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.0322     Document Type: Note

References (10)

1. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546-1558.
2. DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry. 2007;164(4):582-590.
3. Post RM. Epigenetic basis of sensitization to stress, affective episodes, and stimulants: Implications for illness progression and prevention. Bipolar Disord. 2016;18(4):315-324.
4. Hamilton PJ, Burek DJ, Lombroso SI, et al. Cell-type-specific epigenetic editing at the Fosb gene controls susceptibility to social defeat stress. Neuropsychopharmacology. 2018;43(2):272-284.
5. McGowan PO, Sasaki A, D'Alessio AC, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009;12(3):342-348.
6. Kessing LV, Hansen HV, Hvenegaard A, et al; Early Intervention Affective Disorders (EIA) Trial Group. Treatment in a specialised out-patient mood disorder clinic v standard out-patient treatment in the early course of bipolar disorder: Randomised clinical trial. Br J Psychiatry. 2013;202(3):212-219.
7. Kozicky JM, Torres IJ, Silveira LE, Bond DJ, Lam RW, Yatham LN. Cognitive change in the year after a first manic episode: Association between clinical outcome and cognitive performance early in the course of bipolar I disorder. J Clin Psychiatry. 2014; 75(6):e587-e593.
8. Berk M, Daglas R, Dandash O, et al. Quetiapine v lithium in the maintenance phase following a first episode of mania: Randomised controlled trial. Br J Psychiatry. 2017;210(6):413-421.
9. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2): A42.
10. Post RM, Altshuler LL, Kupka R, et al. More childhood onset bipolar disorder in the United States than Canada or Europe: Implications for treatment and prevention. Neurosci Biobehav Rev. 2017;74(pt A):204-213.